A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
Alternate their use (e.g., GHK-Cu in the morning, other actives at night, or on alternate days)
Overgaard RV, Hertz CL, Ingwersen SH, Navarria A, Drucker DJ
With a Glutathione and Vitamin C treatment, people can reduce the risk of getting sick by strengthening the immune system
Hazel nuts
Also, your insurance may not cover Ozempic if you are using this diabetes drug off-label for weight loss